TransMedics Group, Inc. (TMDX)

NASDAQ

$123.07

-$3.72 (2.93%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$122.54$129.75

Open $127.79

52 Week Range

$55.00$156.00

Previous Close $126.79

Market Cap4.21B

Volume721.72K

Avg Volume924.23K

P/E (TTM)45.75

EPS (TTM)$2.69

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for TransMedics Group, Inc.

NOV182025

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Source: PRNewsWire•27 days ago

ANDOVER, Mass. , Nov. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announ...

OCT312025

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Source: PRNewsWire•45 days ago

ANDOVER, Mass. , Oct. 31, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announ...

OCT292025

TransMedics Reports Third Quarter 2025 Financial Results

Source: PRNewsWire•47 days ago

ANDOVER, Mass. , Oct. 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today report...

OCT152025

TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025

Source: PRNewsWire•61 days ago

ANDOVER, Mass. , Oct. 15, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announc...

SEP222025

TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy

Source: PRNewsWire•85 days ago

Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program ("NOP") hubs in Italy to support utilization of TransMedics' Organ Care System ("OCS") perfusion technology and increase donor organ utilization for pat...